BrainChip Engages VVDN to Deliver Industry’s First Commercial Edge Box Based on Neuromorphic Technology
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first…
Newly constructed building offers modern storage capacity, a huge capacity for new customers, and service…
WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Full commercial launch of NexoBrid marks important first step to becoming the new standard of…
DALLAS, Sept. 20, 2023 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI”…
Full commercial launch of NexoBrid marks important first step to becoming the new standard of…
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
DALLAS, Sept. 20, 2023 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI”…
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading…
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023…
Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023…
Strategic Realignment Designed to Right Size Organization to Address Macro Pharma Market Financing Challenges and…
Strategic Realignment Designed to Right Size Organization to Address Macro Pharma Market Financing Challenges and…
– On Track to Report Initial Data from the Global, Multiple Ascending Dose Phase 1/2…
PRINCETON, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech…
IRVINE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today…
CAMBRIDGE, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset…